Showing results (901-910 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|July 10, 2020
Sexually dimorphic impact of the iron-regulating gene, HFE, on survival in glioblastomaDarya S Nesterova, Vishal Midya, Brad E Zacharia, et al.
Neuro-Oncology Advances|July 10, 2020
T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiologyMartha Foltyn, Karen Natalia Nieto Taborda, Ulf Neuberger, et al.
Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.
Neuro-Oncology Advances|July 10, 2020
Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospectsJubayer A Hossain, Antonio Marchini, Boris Fehse, et al.
Neuro-Oncology Advances|July 10, 2020
MR-guided focused ultrasound increases antibody delivery to nonenhancing high-grade gliomaCaterina Brighi, Lee Reid, Alison L White, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Neuro-Oncology Advances|July 10, 2020
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activityBirthe Lohmann, Manuela Silginer, Daniel Picard, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
Neuro-Oncology Advances|July 10, 2020
Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypesJoshua D Frenster, Michael Kader, Scott Kamen, et al.
Neuro-Oncology Advances|July 10, 2020
Soluble protein tyrosine phosphatase receptor type Z (PTPRZ) in cerebrospinal fluid is a potential diagnostic marker for gliomaYu Yamanoi, Masazumi Fujii, Yuta Murakami, et al.
Pageof 138